Rachael Rogers
Director, Market Access @GeneDx
Signup · Get unlimited contacts
WORK HISTORY
Director, Market Access @GeneDx
Gaithersburg, MD, US
Lead the payer contracting strategy across a designated region and with key national payers, including Medicare and TRICARE. This involves securing new agreements and optimizing rates, terms, and network positioning.Advance the adoption of coverage and medical policies by providing the latest clinical evidence and professional society guidelines, particularly in support of whole exome and whole genome sequencing.Collaborate cross-functionally with Billing/Revenue Cycle Management, Legal, Sales, Marketing, and Training teams to ensure a cohesive strategy, streamline contract execution, and achieve reimbursement success.Serve as a subject matter expert on payer policies, health technology assessments (HTAs), lab benefit management programs, relevant legislation, and market trends that impact coverage and reimbursement.Analyze payer performance data to identify opportunities for improvement, address barriers, and lead initiatives that enhance reimbursement outcomes.Provide strategic Market Access guidance to the specific Regions commercial team to support volume and revenue goals.Build and strengthen relationships with payers, health systems, advocacy groups, state legislators, lobbyists, and key opinion leaders to influence policy and expand access.Act as an internal advisor to senior leadership by translating the evolving payer landscape into actionable insights and strategic recommendations.Tackle complex challenges by integrating cross-functional expertise and external insights to drive meaningful and scalable solutions.
EDUCATION
Plymouth State University
Bachelor of Arts (B.A.), Technical and Scientific Communication / English
ABOUT RACHAEL ROGERS
I’m a tenured Market Access Executive who thrives at the intersection of strategy, reimbursement, and patient access. Over the years, I’ve led national contracting efforts, secured favorable PLA coding and CMS reimbursement, and built billing infrastructures that support both scalability and sustainability. I’ve worked across therapeutic areas and payer types, always focused on translating innovation into access with clarity and precision. Whether negotiating with national payers, streamlining revenue cycle operations, or partnering with cross-functional teams, I bring a deep understanding of how policy, pricing, and process work together to shape outcomes.‣ Coding Leadership: Led successful PLA code development and submission for a novel diagnostic assay, ensuring market access readiness and long-term payer alignment from launch.‣ Reimbursement Strategy: Secured CMS acceptance of a proprietary crosswalk recommendation for a PLA code, resulting in a reimbursement rate over 400% above the test’s cost of goods sold.‣ Revenue Generation: Achieved $195K in revenue during the first month of go-live claims billing by aligning coding, pricing, and evidence strategy to support favorable payer reimbursement.‣ Strategic Planning: Directed $3B in national healthcare professional contracting efforts by leading strategic planning for both diagnostic laboratory and medical injectable drug access, aligning payer requirements with provider partnerships.What drives me is the impact, ensuring that groundbreaking diagnostics and therapies don’t just exist, but reach the people who need them. I’m now looking for my next opportunity to help a mission-driven organization navigate the evolving market access landscape and accelerate the diagnostic pathway journey.“Dream big. Start small. But most of all, start.” – Simon Sinek
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.